VANTAS
LOE Approachinghistrelin acetate
NDASUBCUTANEOUSIMPLANT
Approved
Oct 2004
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Drug data last refreshed 14h ago · AI intelligence enriched 4w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VANTAS (histrelin acetate) is a subcutaneous implant that delivers sustained gonadotropin-releasing hormone (GnRH) agonist therapy. It is indicated for palliative treatment of advanced prostate cancer in men. The implant provides continuous hormone suppression over a 12-month period with a single placement.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure; brand teams should focus on retention strategies and cost management initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Prospective Multicentre Non-interventional Study of VANTAS® for the Treatment of Patients With Advanced Prostate Cancer
Started Jan 2011
142 enrolled
Prostate Cancer
Career Relevance
Working on VANTAS offers stability in a mature oncology franchise with established customer relationships and reimbursement pathways. However, LOE approaching means career growth is limited to defensive strategies, market share protection, and transitioning to newer pipeline assets within the company.
Brand Manager
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.